论文部分内容阅读
目的对在进行人流手术前24h口服米非司酮对早孕者扩张宫颈的效果进行探讨。方法将150例7～11周的早孕者分成三组,第一组在进行人流手术前24h顿服75mg米非司酮,第二组在进行人流手术时在宫颈旁注射2%的利多卡因,第三组未作任何处理为对照组。根据情况对在进行人流手术时三组的宫颈扩张效果和手术时间比较分析。结果第一组在进行人流手术时,不需要扩张宫颈,且所用手术时间最短,与其他两组进行差异比较,有明显的显著意义。结论在进行人流手术前24h口服75mg的米非司酮对早孕者宫颈扩张有良好的效果,缩短手术时间,缓解手术所带来的疼痛。
Objective To evaluate the effect of oral administration of mifepristone on cervical dilatation of pregnant women at 24 hours before abortion. Methods 150 pregnant women with 7-11 weeks of age were divided into three groups. The first group received 75 mg of mifepristone once a day before abortion and the second group received 2% lidocaine at the cervix during abortion. , The third group without any treatment as control group. According to the situation on the abortion in the three groups of cervical dilatation and operation time comparative analysis. Results The first group did not need to dilate the cervix during the abortion, and the operation time was the shortest. Compared with the other two groups, there was significant significance. Conclusions Oral administration of 75 mg of mifepristone has a good effect on cervical dilatation of pregnant women at 24 hours before abortion, shortening the operation time and relieving the pain caused by the operation.